Boston Scientific earnings were $3.6B for the trailing 12 months ending Mar 31, 2026, with 74.6% growth year over year. The latest BSX earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.3B, up 99.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BSX reported annual earnings of $2.9B, with 56.4% growth.
BSX past earnings growth
How has BSX's earnings growth performed historically?
What were Boston Scientific's earnings last quarter?
On BSX's earnings call on Invalid Date, Boston Scientific (NYSE: BSX) reported Q1 2026 earnings per share (EPS) of $0.90, up 95.65% year over year. Total BSX earnings for the quarter were $1.34 billion. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.46.
As of the last Boston Scientific earnings report, Boston Scientific is currently profitable. Boston Scientific's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $3.57 billion, a 75.44% increase year over year.
What was BSX's earnings growth in the past year?
As of Boston Scientific's earnings date in Invalid Date, Boston Scientific's earnings has grown 74.64% year over year. This is 63.31 percentage points higher than the US Medical Devices industry earnings growth rate of 11.32%. BSX earnings in the past year totalled $3.57 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.